Heron Therapeutics (HRTX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Heron Therapeutics (HRTX) over the last 13 years, with Q3 2025 value amounting to -$708000.0.
- Heron Therapeutics' Other Gross PP&E Adjustments rose 7959.07% to -$708000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$708000.0, marking a year-over-year increase of 7959.07%. This contributed to the annual value of $22.0 million for FY2024, which is 11905.81% up from last year.
- Latest data reveals that Heron Therapeutics reported Other Gross PP&E Adjustments of -$708000.0 as of Q3 2025, which was up 7959.07% from -$1.4 million recorded in Q2 2025.
- Heron Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $22.0 million for Q4 2024, and its period low was -$15.6 million during Q1 2021.
- Its 5-year average for Other Gross PP&E Adjustments is -$4.6 million, with a median of -$6.1 million in 2023.
- Per our database at Business Quant, Heron Therapeutics' Other Gross PP&E Adjustments soared by 1450.19% in 2021 and then skyrocketed by 182264.15% in 2023.
- Heron Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$12.1 million in 2021, then surged by 95.18% to -$583000.0 in 2022, then surged by 1822.64% to $10.0 million in 2023, then skyrocketed by 119.06% to $22.0 million in 2024, then tumbled by 103.22% to -$708000.0 in 2025.
- Its last three reported values are -$708000.0 in Q3 2025, -$1.4 million for Q2 2025, and -$2.1 million during Q1 2025.